The diagnosis of PRMS was established postoperatively based on histological and immunohistochemical findings, which revealed positive staining for desmin and MyoD1 (myogenic differentiation 1) and negative staining for h-caldesmon and SMA (smooth muscle actin), helping to exclude smooth muscle tumors such as leiomyosarcoma. The gene discussed is MYOD1; the disease is smooth muscle tumor.